Catalyst Wire Dossier Catalyst Wire Dossier

Naftifine Hydrochloride Cream 2%

naftifine hydrochloride · Sun Pharmaceutical Industries, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Naftifine Hydrochloride Cream 2%, covering 2017-05-09 to 2017-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis [Phase 1]

See pricing